ADUS — Addus HomeCare Corporation
Addus HomeCare Corporation trades under the ticker ADUS on NASDAQ.
It operates in the HEALTHCARE sector (MEDICAL CARE FACILITIES).
If you are here to check Addus HomeCare Corporation before deciding, you get an interactive chart, momentum and risk scores, current headlines and alerts you can set on ADUS.
The scores shown here come from a model trained on real market data across seven technical indicators; it estimates both the probability of a rise and the level of risk, and shows both openly.
What ADUS is
Addus HomeCare Corporation, provides personal care services to the elderly, the chronically ill, the disabled, and people who are at risk of hospitalization or institutionalization in the United States. The company is headquartered in Frisco, Texas.…
Addus HomeCare Corporation is classified under HEALTHCARE, in the MEDICAL CARE FACILITIES industry.
It trades on NASDAQ as a common stock.
ADUS size and valuation
At roughly $2.12B, ADUS is a mid-cap.
It earns 5.71 per share and trades at 19.8 times that.
Beta is 0.83: historically it has moved roughly with the market.
ADUS over the past year
Over the past year ADUS has traded between $87.95 and $124.44, and the current price sits at 100% of that range.
Near the top of its 52-week range, the stock is close to the best price it has carried in a year.
The 50-day average is $116.73 against a 200-day average of $105.64 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $134.08, 7.9% above it. A target is an aggregate of opinions, not a measurement.
How Addus HomeCare Corporation (ADUS) is trading
Addus HomeCare Corporation (ADUS) is down 1.97% at $124.31.
The session ranged from $123.64 to $125.91 — 1.8% of the share price — and the current price sits at 30% of that range.
It opened at $124.59 against a previous close of $126.81 — an opening gap of -1.8%, which almost always comes from information released outside trading hours.
The day's range extended past the previous close ($126.81) on both sides.
Volume ran near 276.6K shares, about $34.4M of stock changing hands.
Traded alongside ADUS
Names traded alongside ADUS in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ADUS
Two statistical models run over ADUS inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Instrument details
- Symbol: ADUS
- Name: Addus HomeCare Corporation
- Sector: HEALTHCARE
- Industry: MEDICAL CARE FACILITIES
- Exchange: NASDAQ
- Instrument: Stock
ADUS — frequently asked questions
What is the market cap of ADUS?
Addus HomeCare Corporation has a market capitalisation of roughly $2.12B.
What is the 52-week range for ADUS?
ADUS has traded between $87.95 and $124.44 over the past year, with the current price at 100% of that range.
What is the P/E ratio of ADUS?
ADUS trades at 19.8 times earnings, on earnings per share of 5.71.
How much does ADUS stock cost today?
Addus HomeCare Corporation (ADUS) trades at $124.31, a change of -1.97% in the latest session.
Is ADUS up or down today?
ADUS is down 1.97% in the latest session, at $124.31.
What is the daily trading range for ADUS?
ADUS traded between $123.64 and $125.91 in the latest session, and currently trades at $124.31.
What is the trading volume for ADUS?
ADUS traded roughly 276.6K shares in the latest session.
Which exchange is ADUS listed on?
ADUS is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ADUS stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ADUS figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
More HEALTHCARE stocks
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08